GLP1 Peptide Vial New Zealand
GLP1 Peptide Vial New Zealand (Glucagon-like peptide-1) is an amino acid hormone of 30 to 31 long peptide derived from the post-traduction tissue-like treatment of proglucagon peptide.
Glucagon-like peptide 1 (GLP-1), particularly after food, allows you to control your appetite, by slowing down the digestive system. It also leads to the increase of insulin production. In the intestine is rendered GLP-1. The primary source of GLP-1 are the cells in the small intestine.
GLP-1, also called Liraglutide, has been approved by the FDA to help people lose weight and treat type 2 diabetes.
Benefits of GLP1 Peptide Vial New Zealand
- Reduces the chance of developing diabetes by lowering blood sugar levels.
- Reduces the risk of heart disease.
- Suppresses appetite and aids in weight reduction.
- Enhances memory and cognition while reducing the risk of neurodegenerative disorders like Alzheimer’s.
Amino Acid Sequence: H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2
Molecular Formula: C149H226N40O45
DISCLAIMER: We do not supply Peptides or Sarms to any individual under the age of 21. You must be a licensed and qualified healthcare practitioner. All products listed on this website (https://pharmagrade.store) and provided through Pharma Grade are intended ONLY FOR medical research purposes. Pharma Grade New Zealand does not encourage or promote the use of any of these products in a personal capacity (i.e. human consumption) nor are the products intended as a drug, stimulant or for use in any food products.